Reichelt; Claudia

Patent Applications and Registrations

Patent applications and USPTO patent grants for Reichelt; Claudia.The latest application filed is for "trypsin-like serine protease inhibitors, and their preparation and use".

Company Profile

0.12.9

Reichelt; Claudia - Leipzig DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Trypsin-like serine protease inhibitors, and their preparation and use Grant 9,611,290 - Herold , et al. April 4, 2	2017-04-04
Trypsin-like Serine Protease Inhibitors, And Their Preparation And Use App 20140073573 - HEROLD; Peter ; et al.	2014-03-13
Substituted 5H-pyrimido[5,4-B]indoles, method for the production thereof and use thereof for treating non-solid malignant tumors of the blood-producing system Grant 8,664,233 - Reichelt , et al. March 4, 2	2014-03-04
Trypsin-like serine protease inhibitors, and their preparation and use Grant 8,598,206 - Herold , et al. December 3, 2	2013-12-03
Trypsin-like serine protease inhibitors, and their preparation and use Grant 8,513,461 - Steinmetzer , et al. August 20, 2	2013-08-20
Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors IIa and Xa Grant 8,497,245 - Herold , et al. July 30, 2	2013-07-30
Trypsin-like Serine Protease Inhibitors, And Their Preparation And Use App 20130165510 - STEINMETZER; Torsten ; et al.	2013-06-27
Trypsin-like serine protease inhibitors, and their preparation and use Grant 8,410,310 - Steinmetzer , et al. April 2, 2	2013-04-02
Trypsin-like Serine Protease Inhibitors, Their Preparation And Use As Selective Inhibitors Of The Clotting Factors Iia And Xa App 20120252743 - Herold; Peter ; et al.	2012-10-04
Trypsin-like Serine Protease Inhibitors, And Their Preparation And Use App 20120225913 - STEINMETZER; Torsten ; et al.	2012-09-06
Trypsin-like serine protease inhibitors, and their preparation and use Grant 8,207,378 - Steinmetzer , et al. June 26, 2	2012-06-26
SUBSTITUTED PYRIDO [3', 2': 4, 5] THIENO [3, 2-D] PYRIMIDINES AND PYRIDO [3', 2': 4, 5] FURO [3, 2-D] PYRIMIDINES USED AS INHIBITORS OF THE PDE-4 AND/OR THE RELEASE OF TNF-alpha App 20120094987 - Reichelt; Claudia ; et al.	2012-04-19
Trypsin-like Serine Protease Inhibitors, And Their Preparation And Use App 20110301196 - HEROLD; Peter ; et al.	2011-12-08
Substituted pyrido [3', 2': 4, 5] thieno [3, 2-D] pyrimidines and pyrido [3', 2': 4, 5] furo [3, 2-D] pyrimidines used as inhibitors of the PDE-4 and/or the release of TNF-ALPHA Grant 8,058,285 - Reichelt , et al. November 15, 2	2011-11-15
Substituted 5h-pyrimido[5,4-b]indoles, Method For The Production Thereof And Use Thereof For Treating Non-solid Malignant Tumors Of The Blood-producing System App 20110021511 - Reichelt; Claudia ; et al.	2011-01-27
Trypsin-like Serine Protease Inhibitors, And Their Preparation And Use App 20100022781 - Steinmetzer; Torsten ; et al.	2010-01-28
Substituted Pyrido [3', 2': 4, 5] Thieno [3, 2-d] Pyrimidines And Pyrido [3', 2': 4, 5] Furo [3, 2-d] Pyrimidines Used As Inhibitors Of The Pde-4 And/or The Release Of Tnf-alpha App 20080160028 - Reichelt; Claudia ; et al.	2008-07-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.